Tag: NASDAQ:RNA

FB Nasdaq FB Facebook
Finance

Bullish Stocks At NASDAQ: Techne Corporation (NASDAQ:TECH), Flamel Technologies (NASDAQ:FLML), Prosensa Holding (NASDAQ:RNA), Alliance Fiber Optic Products (NASDAQ:AFOP)

Techne Corporation (NASDAQ:TECH), a Minneapolis hematology specialist also known as Bio-Techne Corporation (NASDAQ:TECH), shot past expectations with revenue of $95.6 million, well above the expected $92.5 million, and adjusted earnings per share of 94 cents, which was 5 cents above expectations. Techne Corporation (NASDAQ:TECH) stock performance was 8.30% in last session and finished the day at $90.84. Traded volume was 450,920.00million shares in the last … Continue reading Bullish Stocks At NASDAQ: Techne Corporation (NASDAQ:TECH), Flamel Technologies (NASDAQ:FLML), Prosensa Holding (NASDAQ:RNA), Alliance Fiber Optic Products (NASDAQ:AFOP)

Kristen Barton
Finance

Active Watch List: 3D Systems Corporation (NYSE:DDD), FactSet Research Systems (NYSE:FDS), Aspen Insurance Holdings Ltd. (NYSE:AHL), Simpson (NYSE:SSD), Prosensa (NASDAQ:RNA)

On August 12,2014 3D Systems (NYSE:DDD) announced that it has signed a lease on a new 200,000 square foot facility in Rock Hill, South Carolina, increasing its manufacturing and distribution capacity to meet growing demand for its 3D printers and materials. The addition of this new manufacturing and distribution center is part of the company’s previously announced expansion, which is expected to generate hundreds of new … Continue reading Active Watch List: 3D Systems Corporation (NYSE:DDD), FactSet Research Systems (NYSE:FDS), Aspen Insurance Holdings Ltd. (NYSE:AHL), Simpson (NYSE:SSD), Prosensa (NASDAQ:RNA)

Chris Lewis
Finance

Active Stocks : Prosensa Holding (NASDAQ:RNA), Blucora (NASDAQ:BCOR), Foster Wheeler (NASDAQ:FWLT), Five Oaks Investment Corp. (NYSE:OAKS), AirMedia Group Inc. (NASDAQ:AMCN)

The Rosen Law Firm, P.A. reminds all purchasers of Prosensa Holding N.V. (NASDAQ:RNA) ordinary shares of the important September 16, 2014 lead plaintiff deadline in the class action.  Prosensa Holding N.V. (NASDAQ:RNA) belongs to Healthcare sector. Its net profit margin is -27.60% and weekly performance is 1.46%. On last trading day company shares ended up $9.76. Prosensa Holding N.V. (NASDAQ:RNA) distance from 50-day simple moving … Continue reading Active Stocks : Prosensa Holding (NASDAQ:RNA), Blucora (NASDAQ:BCOR), Foster Wheeler (NASDAQ:FWLT), Five Oaks Investment Corp. (NYSE:OAKS), AirMedia Group Inc. (NASDAQ:AMCN)

Mark Doerr
Finance

Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on July 9 announced the pricing of its underwritten public offering of 2,017,349 shares of its common stock at a price to the public of $40.00 per share, before underwriting discounts. Ultragenyx is selling 1,311,277 shares of its common stock in this offering, and certain selling stockholders are selling 706,072 shares of common stock in this offering. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) … Continue reading Biotech Stocks: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Prosensa Holding NV (NASDAQ:RNA), Agios Pharmaceuticals Inc (NASDAQ:AGIO), Seattle Genetics, Inc. (NASDAQ:SGEN), Idera Pharmaceuticals Inc (NASDAQ:IDRA)

Adam Keintzel
Finance

Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Prosensa Holding NV (NASDAQ:RNA) was upgraded by stock analysts at KBC Securities from a “hold” rating to an “accumulate” rating in a report issued on Wednesday. The firm currently has a $11.00 price objective on the stock, up from their previous price objective of $7.00. KBC Securities’ target price would indicate a potential upside of 1.57% from the company’s current price. Prosensa Holding NV (NASDAQ:RNA) … Continue reading Volatile Stocks: Prosensa Holding (NASDAQ:RNA), 22nd Century Group Inc (NYSEMKT:XXII), Alnylam Pharmaceuticals (NASDAQ:ALNY), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)

Colin Pettis